- Home
- SOPH vs AXGN Comparison
SOPH vs AXGN Comparison
Compare SOPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- AXGN
- Stock Information
- Founded
- SOPH 2011
- AXGN N/A
- Country
- SOPH Switzerland
- AXGN United States
- Employees
- SOPH N/A
- AXGN N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SOPH Health Care
- AXGN Health Care
- Exchange
- SOPH Nasdaq
- AXGN Nasdaq
- Market Cap
- SOPH 247.0M
- AXGN 584.7M
- IPO Year
- SOPH 2021
- AXGN N/A
- Fundamental
- Price
- SOPH $3.40
- AXGN $13.28
- Analyst Decision
- SOPH Strong Buy
- AXGN Strong Buy
- Analyst Count
- SOPH 3
- AXGN 4
- Target Price
- SOPH $7.00
- AXGN $15.00
- AVG Volume (30 Days)
- SOPH 21.9K
- AXGN 370.0K
- Earning Date
- SOPH 11-05-2024
- AXGN 11-05-2024
- Dividend Yield
- SOPH N/A
- AXGN N/A
- EPS Growth
- SOPH N/A
- AXGN N/A
- EPS
- SOPH N/A
- AXGN N/A
- Revenue
- SOPH $64,938,000.00
- AXGN $173,482,000.00
- Revenue This Year
- SOPH $7.70
- AXGN $18.49
- Revenue Next Year
- SOPH $20.61
- AXGN $12.78
- P/E Ratio
- SOPH N/A
- AXGN N/A
- Revenue Growth
- SOPH 20.14
- AXGN 17.26
- 52 Week Low
- SOPH $2.70
- AXGN $3.45
- 52 Week High
- SOPH $7.37
- AXGN $15.23
- Technical
- Relative Strength Index (RSI)
- SOPH 44.10
- AXGN 45.87
- Support Level
- SOPH $3.22
- AXGN $12.84
- Resistance Level
- SOPH $3.66
- AXGN $15.23
- Average True Range (ATR)
- SOPH 0.20
- AXGN 0.65
- MACD
- SOPH 0.01
- AXGN -0.17
- Stochastic Oscillator
- SOPH 58.60
- AXGN 18.41
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.